v3.25.1

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current Assets:
Cash and cash equivalents	$ 75,592	$ 56,087
Marketable investments	58,662	48,582
Accounts receivable, net of allowance for expected credit losses of $372 and $434 as of March 31, 2025 and December 31, 2024, respectively	43,251	55,490
Deferred commissions	21,085	22,942
Prepaid expenses and other current assets	19,909	18,263
Total current assets	218,499	201,364
Property and equipment, net	10,996	11,699
Operating lease right-of-use assets	24,802	27,049
Goodwill	145,267	227,959
Intangible assets, net	25,258	27,475
Other assets	14,984	8,316
Total assets	439,806	503,862
Current Liabilities:
Accounts payable	422	965
Accrued expenses and other current liabilities	42,685	57,602
Deferred revenue	180,580	145,404
Total current liabilities	223,687	203,971
Long-term debt	35,000	35,000
Non-current operating lease liabilities	21,999	24,809
Other non-current liabilities	11,686	10,545
Total liabilities	292,372	274,325
Commitments and contingencies (Note 16)
Stockholders' Equity :
Preferred stock, $0,01 par value Authorized - 500 shares; issued and outstanding - none	0	0
Common stock, $0.01 par value Authorized - 125,000 shares Issued - 25,262 and 25,119 shares as of March 31, 2025 and December 31, 2024, respectively Outstanding - 18,980 and 18,838 shares as of March 31, 2025 and December 31, 2024, respectively	253	251
Additional paid-in capital	294,922	292,217
Retained earnings	84,662	171,934
Treasury stock - 6,282 shares as of March 31, 2025 and December 31,2024	(227,119)	(227,119)
Accumulated other comprehensive loss	(5,284)	(7,746)
Total stockholders’ equity	147,434	229,537
Total liabilities and stockholders’ equity	$ 439,806	$ 503,862

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

FORRESTER RESEARCH, INC. 10-Q